FUJIFILM Diosynth Biotechnologies To Double Holly Springs Biomanufacturing Campus

FUJIFILM Diosynth Biotechnologies is investing $1.2 billion to double the size of its manufacturing facility in Holly Springs, North Carolina. The expanded facility will be the largest end-to-end cell culture CDMO facility in North America and is expected to create 680 high-paying jobs in manufacturing, engineering, administration, and both quality assurance and control. The Economic Investment Committee of the North Carolina Department of Commerce has approved a Job Development Investment Grant of nearly $15 million to support the project. Continue reading to learn more about this investment and its impact on Holly Springs and the broader Wake County community.